<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2000-05-31</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001106773</issuerCik>
        <issuerName>FIRST HORIZON PHARMACEUTICAL CORP</issuerName>
        <issuerTradingSymbol>FHRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001303544</rptOwnerCik>
            <rptOwnerName>Kapoor-Pharma Investments, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>225 EAST DEERPATH</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 250</rptOwnerStreet2>
            <rptOwnerCity>LAKE FOREST</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60045</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>President CEO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6487583</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <remarks>Heretofore, the holdings of Kapoor-Pharma Investments, LP have been beneficially reported on the Section 16 reports of Dr. John Kapoor, its ultimate principal.  However, upon reconsideration of the nature of the relationship between Kapoor-Pharma and Dr. Kapoor, it was decided that Kapoor-Pharma should separately report its holdings of First Horizon common stock on a going forward basis.</remarks>

    <ownerSignature>
        <signatureName>/s/ John N. Kapoor, Ph. D.</signatureName>
        <signatureDate>2004-09-28</signatureDate>
    </ownerSignature>
</ownershipDocument>

